These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16498048)

  • 1. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
    Bohbot NL; Young J; Orgiazzi J; Buffet C; François M; Bernard-Chabert B; Lukas-Croisier C; Delemer B
    Eur J Endocrinol; 2006 Mar; 154(3):367-72. PubMed ID: 16498048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report.
    Kim BK; Choi YS; Park YH; Lee SU
    J Korean Med Sci; 2011 Dec; 26(12):1638-41. PubMed ID: 22148004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subacute thyroiditis with cell destruction and temporary hyperthyroidism in Graves'disease--case report].
    Pichler R; Wölfl S; Bogner S; Sulzbacher H; Shamiyeh A; Maschek W
    Acta Med Austriaca; 2002; 29(4):137-40. PubMed ID: 12424939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
    Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
    Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?
    Minelli R; Valli MA; Di Seclì C; Finardi L; Chiodera P; Bertoni R; Ferrari C; Barilli AL; Coiro V; Saccani Jotti G; Delsignore R
    Horm Res; 2005; 63(4):194-9. PubMed ID: 15860921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C.
    Koizumi S; Mashio Y; Mizuo H; Matsuda A; Matsuya K; Mizumoto H; Ikota A; Beniko M; Iriuda Y
    Intern Med; 1995 Jan; 34(1):58-60. PubMed ID: 7718983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C.
    Inoue A; Koizumi S; Matsuda A; Mizuo H; Iriuda Y; Ikota A; Beniko M; Kosugi T; Matsuya K; Kunita H; Mashio Y
    Endocr J; 2005 Jun; 52(3):293-8. PubMed ID: 16006723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report.
    Duncea I; Pepene CE
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):453-6. PubMed ID: 19104709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
    Ito M; Takamatsu J; Yoshida S; Murakami Y; Sakane S; Kuma K; Ohsawa N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):616-9. PubMed ID: 9024264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues.
    Amino N; Hidaka Y; Takano T; Tatsumi KI; Izumi Y; Nakata Y
    Thyroid; 2003 Aug; 13(8):815-8. PubMed ID: 14558924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: silent thyroiditis developed during alpha-interferon therapy.
    Kamikubo K; Takami R; Suwa T; Kawase Y; Shiroko J; Kametani M; Tokimitsu N; Sakata S
    Am J Med Sci; 1993 Sep; 306(3):174-6. PubMed ID: 8128980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine.
    Czarnywojtek A; Waligórska-Stachura J; Szczepanek E; Zgorzalewicz-Stachowiak M; Bereszyńska I; Kurdybacha P; Stangierski A; Harasymczuk J; Florek E; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):268-72. PubMed ID: 22635082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
    Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
    Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
    Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Diagnostic Accuracy of Thyroid-Stimulating Hormone (TSH) Receptor Antibodies in Distinguishing Graves' Disease and Subacute Thyrotoxicosis in the Indian Population.
    Naga Nitin LT; Lakkundi S; S L SR; Shanthaiah DM; Datta SG; Annavarapu U; Sarathi V
    Cureus; 2024 Feb; 16(2):e54303. PubMed ID: 38496158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
    Momotani N; Noh J; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):285-9. PubMed ID: 7913091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.